Study suggests limits on opioid dosage may not reduce overdoses

09/17/2013 | Medscape (free registration)

Restricting daily morphine dosages to 100 mg may not be an effective strategy to reduce overdoses, according to Purdue Pharma research released at PAINWeek 2013. The study, which cited age, sedative use and lack of a recent opioid prescription as factors in overdose risk, followed recommendations from Physicians for Rational Opioid Prescribing that included limiting doses for noncancer pain.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY